Dolby Laboratories (DLB) Cash & Equivalents (2016 - 2025)
Dolby Laboratories (DLB) has disclosed Cash & Equivalents for 17 consecutive years, with $643.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents rose 23.62% year-over-year to $643.8 million, compared with a TTM value of $643.8 million through Dec 2025, up 23.62%, and an annual FY2025 reading of $701.9 million, up 45.61% over the prior year.
- Cash & Equivalents was $643.8 million for Q4 2025 at Dolby Laboratories, down from $701.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $1.2 billion in Q3 2021 and bottomed at $482.0 million in Q3 2024.
- Average Cash & Equivalents over 5 years is $762.5 million, with a median of $701.9 million recorded in 2025.
- The sharpest move saw Cash & Equivalents plummeted 49.39% in 2022, then soared 45.61% in 2025.
- Year by year, Cash & Equivalents stood at $1.1 billion in 2021, then crashed by 40.74% to $626.2 million in 2022, then rose by 4.9% to $656.8 million in 2023, then decreased by 20.71% to $520.8 million in 2024, then grew by 23.62% to $643.8 million in 2025.
- Business Quant data shows Cash & Equivalents for DLB at $643.8 million in Q4 2025, $701.9 million in Q3 2025, and $698.6 million in Q2 2025.